PubMed

Accounting for the increase in NSAID expenditure: substitution or leakage?

Barton GR, Avery AJ, Whynes DK.

Cost Eff Resour Alloc. 2006 May 31;4:9.PMID: 16737538 [PubMed]Free PMC ArticleFree textRelated citations

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.

Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.

Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.PMID: 18405470 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Utilisation Pattern of Nonspecific Nonsteroidal Anti-Inflammatory Drugs and COX-2 Inhibitors in a Local Health Service Unit in Northeast Italy.

Chiroli S, Chinellato A, Didoni G, Mazzi S, Lucioni C.

Clin Drug Investig. 2003;23(11):751-60.PMID: 17536889 [PubMed - in process]Related citations

Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.

Rahme E, Watson DJ, Kong SX, Toubouti Y, LeLorier J.

Pharmacoepidemiol Drug Saf. 2007 May;16(5):493-503.PMID: 17086567 [PubMed - indexed for MEDLINE]Related citations

Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.

Rahme E, Nedjar H.

Rheumatology (Oxford). 2007 Mar;46(3):435-8. Epub 2007 Jan 25.PMID: 17255138 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Initiation of antihypertensive therapy among new users of cyclooxygenase-2-selective and nonselective NSAIDs.

Langman MJ, Eichler HG, Mavros P, Watson DJ, Kong SX.

Int J Clin Pharmacol Ther. 2004 May;42(5):260-6.PMID: 15176648 [PubMed - indexed for MEDLINE]Related citations

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.

Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.PMID: 17018227 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.

Schneeweiss S, Solomon DH, Wang PS, Rassen J, Brookhart MA.

Arthritis Rheum. 2006 Nov;54(11):3390-8.PMID: 17075817 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.

Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, Worchel J.

Drug Saf. 2006;29(7):621-32.PMID: 16808554 [PubMed - indexed for MEDLINE]Related citations

Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.

Layton D, Souverein PC, Heerdink ER, Shakir SA, Egberts AC.

Drug Saf. 2008;31(2):143-58.PMID: 18217790 [PubMed - indexed for MEDLINE]Related citations

Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.

Huang WF, Hsiao FY, Wen YW, Tsai YW.

Clin Ther. 2006 Nov;28(11):1827-36.PMID: 17213003 [PubMed - indexed for MEDLINE]Related citations

Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.

Moride Y, Ducruet T, Boivin JF, Lavoie F, Rochon S.

Can J Clin Pharmacol. 2005 Summer;12(2):e201-11. Epub 2005 Jun 17.PMID: 15998959 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile.

Arellano FM, Yood MU, Wentworth CE, Oliveria SA, Rivero E, Verma A, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2006 Dec;15(12):861-72.PMID: 17086563 [PubMed - indexed for MEDLINE]Related citations

Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization.

Sun SX, Lee KY, Bertram CT, Goldstein JL.

Curr Med Res Opin. 2007 Aug;23(8):1859-66.PMID: 17605893 [PubMed - indexed for MEDLINE]Related citations

Uptake of COX-2 selective inhibitors and influence on NSAID prescribing in Northern Ireland.

Girvin B, Rafferty T, Stevenson MR, Johnston GD.

Pharmacoepidemiol Drug Saf. 2004 Mar;13(3):153-7.PMID: 15072114 [PubMed - indexed for MEDLINE]Related citations

Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors.

Jick H, Kaye JA, Russmann S, Jick SS.

Pharmacotherapy. 2006 Oct;26(10):1379-87.PMID: 16999647 [PubMed - indexed for MEDLINE]Related citations

The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people.

Fosbøl EL, Gislason GH, Jacobsen S, Abildstrom SZ, Hansen ML, Schramm TK, Folke F, Sørensen R, Rasmussen JN, Køber L, Madsen M, Torp-Pedersen C.

Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):822-33.PMID: 18383428 [PubMed - indexed for MEDLINE]Related citations

Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.

Varas-Lorenzo C, Maguire A, Castellsague J, Perez-Gutthann S.

Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):366-76.PMID: 16897817 [PubMed - indexed for MEDLINE]Related citations

Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.

Thompson PW, Tee L, McBride J, Quincey D, Strat Liddiard G.

Rheumatology (Oxford). 2005 Oct;44(10):1308-10. Epub 2005 Jun 21.PMID: 15972345 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.

Patterson MK, Castellsague J, Walker AM.

Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):982-8.PMID: 18711705 [PubMed - indexed for MEDLINE]Related citations